PRIA Webinar: What You Need to Know About CMS's Proposed WISeR Model
PRIA Healthcare • August 1, 2025
Webinar: Prior Authorization is Coming to Fee-for-Service Medicare -- What You Need to Know About CMS's Proposed WISeR Model
CMS’s proposed WISeR Model is a game changer - and PRIA is here to help you navigate what it means for your providers, patients, and market access strategy.
Hosted by PRIA's EVP of RHEMA, Tonya Dowd and featuring panelists Victoria Wallace, JD, Partner at Hogan Lovells, and Rebecca Holley, Director of Market Access & Reimbursement, Saluda Medical, this webinar explored what the WISeR model is, what innovators need to know, and how they can prepare for the changes it brings to the MedTech landscape.
Click the Icon below to share this with your network
The first in a series on the shifting landscape of patient access, from inside the team that fights for the patient's first stamp on their passport.
FDA authorization does not guarantee timely Medicare coverage. RAPID is CMS’s latest attempt to narrow that gap—and potentially one of its most consequential.
PRIAs webinar, How Payers Decide: Coverage, Evidence, and Value in MedTech Commercialization featuring Dr. Julie Kessel and Dr. Dot Verbrugge
Stop Guessing What FDA Wants
Regulatory Meets Reimbursement: What MedTech Innovators Need to Know About FDA Breakthrough and Beyond
You Got Your 510(k). Now What?
Right Sizing Your Quality System
Five Mistakes MedTech StartUps Make Before Their First VAC Meeting
Using Regulatory as a Strategy and Not a Milestone
An informative article series from PRIA Healthcare's Head of Regulatory and Quality, Sam Murray
Examining the impact of the RAPID program, accelerating Medicare access for Breakthrough Devices by aligning FDA approval & CMS coverage, earlier.
PRIA's experts on reimbursement and regulatory issues weigh in on CMS's proposed NTAP change, and what it may mean for MedTech innovations.
